SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POETs sharp rebound after a steep selloff is driving attention, with bullish traders pointing to a recovery near the companys cash value and speculating about short covering. Others call it a temporary or fake pump and say sustained gains will require confirmed orders, shipments, or production updates; no specific new catalyst is established in the discussion.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The discussion centers on pending top-line overall-survival results from SELLASs phase 3 REGAL trial of GPS, following the reported 80th-event milestone and the move into final analysis. Some traders anticipate favorable data and short covering, while others question the bullish case and point to the stocks sharp decline; the results remain unconfirmed.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results, sharply growing Recorlev sales, and raised revenue outlook are driving the rally, with traders pointing to the improved long-term growth forecast as the main catalyst. The reaction is broadly bullish, while buyout and short-covering theories remain speculation rather than confirmed developments.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year engine, technology-licensing and engineering agreement with AST SpaceMobile is driving attention, with traders viewing it as validation of Fireflys propulsion business and a boost to its backlog and funding outlook. The reaction is broadly bullish, though some question the cash-versus-stock mix, possible dilution and how the deal will affect upcoming earnings.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs quarterly reportshowing record results and a higher full-year revenue outlookis driving attention, with many traders celebrating the beat and stronger growth outlook. Others remain cautious about cash burn, dilution, and how much reported growth reflects acquisitions rather than the core quantum business.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

A sharp rebound after steep losses is drawing attention, with traders pointing to anticipation of NASAs CLPS 2.0 awards and a reported dismissal of a bid protest. The rally is widely welcomed, though traders debate whether it reflects short-covering and a space-sector bounce or a temporary relief move.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

INFQ is rebounding alongside quantum stocks, with traders pointing to Intels move to acquire a quantum company as a boost to sector sentiment and validation of the field. Some see room for short covering after the recent selloff, while others view the rise as a broader sector bounce rather than a new company-specific catalyst.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos Q3 results and agreement to reserve U.S. Forged Rings manufacturing capacity for future Aurora reactors are driving attention alongside a sharp rebound after a prolonged selloff. Bulls see the supply-chain commitment and cash reserves as progress, while bears argue the company remains pre-revenue, richly valued, and exposed to dilution and long execution timelines.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Aduros 120-hour pilot campaign, which included processing real post-consumer plastic and met its condensable-hydrocarbon yield target, is a focus of discussion alongside the stocks sharp move and increased volume. Bulls see progress toward validating HCT, while skeptics argue that pilot results do not establish viable economics or commercial readiness.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Halozyme Therapeutics is seeing significant investor attention following its decision to withdraw a contentious acquisition bid, a move that the market has interpreted as a commitment to fiscal discipline. Investors are now shifting their focus toward the company's core royalty-driven business model, strong earnings growth, and upcoming catalysts like new patent extensions and high-volume autoinjector partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TLRY Stock Slumps 4%: What’s Driving The Selloff?

Equity

Tilray said that it has acquired the BrewDog brand and related intellectual property, UK brewing operations and eleven strategic brewpubs in the United Kingdom and Ireland.


Tilray To Produce And Distribute Carlsberg Beer Brands In US – Stock Gains 4%

The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute several Carlsberg beer brands in all U.S. channels starting Jan. 1, 2027. 


TLRY Stock In Focus After Alliance Global Halves Price Target

Alliance Global cut TLRY’s target price to $10 from $20, citing limited visibility into the company’s long-term sales trajectory and cash flow.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Canopy Growth Stock Drops Pre-Market After Disappointing Q4 Earnings: Retail Terms It ‘A Pretty Big Let Down’

CFO Judy Hong said the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.

Canopy Growth Stock Rises Ahead Of Q2 Report As Pot Producers Await  Clarity On Trump’s Policy

Canopy Growth is looking to solidify its U.S. business, thanks to its two acquisitions in the country this year.

Why This Cannabis Firm Is Among The Top Trending On Stocktwits Today

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago. On the positive side, however, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan

Amplify ETF Trust - Amplify Alternative Harvest ETF

Neutral Sentiment

<ul class="summary-bullets"><li>With the acquisition, the company now sees potential for growth of its U.S. beverage brands in the UK and other international markets. &nbsp;</li><li>Tilray now expects the assets it acquired to generate annual net revenue of &nbsp;about $200 million and adjusted core profit of about $6 - $8 million.</li><li>Tilray on Monday also said that it is separately negotiating the acquisition of certain assets of BrewDog in the U.S. and Australia.<br>&nbsp;</li></ul><p>Shares of Tilray Brands, Inc. (TLRY) fell 4% on Monday after it said that it has completed acquiring certain assets of struggling multinational brewery BrewDog for a total consideration of £33 million ($44.12 million).</p><p>Tilray <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/03/02/3247571/0/en/Tilray-Brands-Acquires-BrewDog-a-Leading-Global-Craft-Brand-Creating-a-500-Million-Global-Craft-Beer-and-Beverage-Platform.html">said</a> that it has acquired the global brand and related intellectual property, UK brewing operations and eleven strategic brewpubs in the United Kingdom and Ireland.</p><p>The cannabis company has a beverage division called Tilray Beverages with a portfolio of craft beers and spirits, among others. With the acquisition, the company now sees potential for growth of its U.S. beverage brands in the UK and other international markets. &nbsp;</p><h2 class="st-heading-2">CEO’s Vision</h2><p>“As we begin a new chapter for this great brand, our priority is to refocus BrewDog on the craft beer excellence that made it beloved in the first place and strategically invest to return the operations to profitable growth,” said Tilray CEO Irwin D. Simon.</p><p>With the BrewDog acquisition, Tilray expects its total global beverage platform to grow to $500 million in annual revenue.</p><p>“On a combined basis, we expect Tilray’s diversified global business to reach ~$1.2 billion in annualized revenue,” Simon added.</p><h2 class="st-heading-2">Financial Terms</h2><p>Tilray now expects the assets it acquired to generate annual net revenue of about $200 million and adjusted core profit of about $6 - $8 million. The acquired business is expected to become cash flow positive beginning in fiscal 2027.</p><p>The company, however, does not anticipate a meaningful core profit contribution in the fourth quarter of fiscal 2026 from the acquisition.</p><h2 class="st-heading-2">Tilray Seeks To Also Acquire BrewDog’s U.S. Assets</h2><p>Tilray on Monday also said that it is separately negotiating the acquisition of certain assets of BrewDog in the U.S. and Australia. The deal to acquire those assets will be covered by a separate purchase agreement which is expected to be finalized and closed in about 30 days, the company said.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around TLRY stayed within the ‘bullish’ territory while message volume rose from ‘low’ to ‘high’ levels.</p><p>A Stocktwits dismissed the acquisition.</p><p><stembedurl>https://www.stocktwits.com/ATLien86/message/646320905</stembedurl></p><p>Another, however, expressed hopes, noting that Tilray bought the assets for cheap.</p><p><stembedurl>https://www.stocktwits.com/kmguy/message/646320680</stembedurl></p><p><a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> has gained 10% over the past 12 months.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/strategy-now-holds-near-55b-in-bitcoin-after-latest-btc-purchase/cZd3aK9RI2E">Strategy Now Holds Near $55 Billion In Bitcoin After Latest BTC Purchase – Company Raises $237 Million Via Share Sale</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the logo of a Canadian pharmaceutical and cannabis company, Tilray, is seen on a smartphone and a PC screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Tilray said that it has acquired the BrewDog brand and related intellectual property, UK brewing operations and eleven strategic brewpubs in the United Kingdom and Ireland.

TLRY Stock Slumps 6%: What’s Driving The Selloff?

Amplify Alternative Harvest ETF

Tilray Brands Inc

Vanguard Health Care ETF

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

MJ Amplify Alternative Harvest ETF

Fundamentals

Latest MJ News